Journey Medical Corp Logo

Journey Medical Corp

A pharmaceutical firm commercializing prescription drugs and generics for dermatology.

DERM | NDAQ

Overview

Corporate Details

ISIN(s):
US48115J1097
LEI:
Country:
United States of America
Address:
9237 E VIA DE VENTURA BLVD., SUITE 105, 85258 SCOTTSDALE
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Journey Medical Corporation is a commercial-stage pharmaceutical company focused on the development and commercialization of prescription products for the treatment of dermatological conditions. The company markets a portfolio of FDA-approved drugs that address common skin issues. Its business strategy includes selling and marketing its branded products, such as Accutane® for severe acne, and offering authorized generics to enhance affordability and patient access. Journey Medical actively seeks to expand its offerings through strategic collaborations, including late-stage licensing and acquisitions, to provide effective solutions for skin health.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Journey Medical Corp filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Journey Medical Corp

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Journey Medical Corp via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Calliditas Therapeutics Logo
Develops and commercializes novel treatments for rare renal and hepatic diseases like IgA nephropathy.
Sweden CALTX
CALTH. Inc Logo
Develops AI-powered rapid diagnostic solutions for point-of-care and self-testing.
South Korea 402420
CAMBRIDGE NUTRITIONAL SCIENCES PLC Logo
Develops and manufactures diagnostic tests for food sensitivity and gut health.
United Kingdom CNSL
Camp4 Therapeutics Corp Logo
Developing RNA-based therapies to upregulate genes for rare metabolic and CNS disorders.
United States of America CAMP
Camurus Logo
Develops long-acting medicines for severe chronic diseases using advanced drug delivery.
Sweden CAMX
Clinical-stage biopharma developing novel cancer drugs aiming for fewer side effects.
Japan 4575
Candel Therapeutics, Inc. Logo
Developing off-the-shelf viral immunotherapies to help the immune system fight solid tumors.
United States of America CADL
Can-Fite BioPharma Ltd. Logo
Develops oral small-molecule drugs targeting A3AR for oncology and inflammatory diseases.
Israel CANF
Can-Fite BioPharma Ltd. Logo
Clinical-stage biopharma developing oral drugs for cancer, inflammatory, liver & metabolic diseases.
United States of America CANF
Cannovum Cannabis AG Logo
Importer & producer of medical cannabis, expanding into recreational cultivation infrastructure.
Germany 27N0

Talk to a Data Expert

Have a question? We'll get back to you promptly.